An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis

M. O. Soares; N. J. Welton; D. A. Harrison; P. Peura; M. Shankar-Hari; S. E. Harvey; J. J. Madan; A. E. Ades; S. J. Palmer; K. M. Rowan

doi:10.3310/hta16070

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis

M. O. Soares, N. J. Welton, D. A. Harrison, P. Peura, M. Shankar-Hari, S. E. Harvey, J. J. Madan, A. E. Ades, S. J. Palmer, K. M. Rowan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-+
Journal	Health Technology Assessment
Volume	16
Issue number	7
DOIs	https://doi.org/10.3310/hta16070
Publication status	Published - Feb 2012

Access to Document

10.3310/hta16070

Cite this

Soares, M. O., Welton, N. J., Harrison, D. A., Peura, P., Shankar-Hari, M., Harvey, S. E., Madan, J. J., Ades, A. E., Palmer, S. J., & Rowan, K. M. (2012). An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technology Assessment, 16(7), 1-+. https://doi.org/10.3310/hta16070

Soares, M. O. ; Welton, N. J. ; Harrison, D. A. et al. / An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. In: Health Technology Assessment. 2012 ; Vol. 16, No. 7. pp. 1-+.

@article{ea0a7cc9e34644609218b1a5a3233533,

title = "An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis",

author = "Soares, {M. O.} and Welton, {N. J.} and Harrison, {D. A.} and P. Peura and M. Shankar-Hari and Harvey, {S. E.} and Madan, {J. J.} and Ades, {A. E.} and Palmer, {S. J.} and Rowan, {K. M.}",

year = "2012",

month = feb,

doi = "10.3310/hta16070",

language = "English",

volume = "16",

pages = "1--+",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "7",

}

Soares, MO, Welton, NJ, Harrison, DA, Peura, P, Shankar-Hari, M, Harvey, SE, Madan, JJ, Ades, AE, Palmer, SJ & Rowan, KM 2012, 'An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis', Health Technology Assessment, vol. 16, no. 7, pp. 1-+. https://doi.org/10.3310/hta16070

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. / Soares, M. O.; Welton, N. J.; Harrison, D. A. et al.
In: Health Technology Assessment, Vol. 16, No. 7, 02.2012, p. 1-+.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis

AU - Soares, M. O.

AU - Welton, N. J.

AU - Harrison, D. A.

AU - Peura, P.

AU - Shankar-Hari, M.

AU - Harvey, S. E.

AU - Madan, J. J.

AU - Ades, A. E.

AU - Palmer, S. J.

AU - Rowan, K. M.

PY - 2012/2

Y1 - 2012/2

U2 - 10.3310/hta16070

DO - 10.3310/hta16070

M3 - Article

SN - 1366-5278

VL - 16

SP - 1-+

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 7

ER -

Soares MO, Welton NJ, Harrison DA, Peura P, Shankar-Hari M, Harvey SE et al. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technology Assessment. 2012 Feb;16(7):1-+. doi: 10.3310/hta16070